(29 days)
No
The device description and performance studies focus on the material properties and mechanical performance of the hip implant components, with no mention of AI or ML.
Yes
The device is a component of a total hip arthroplasty, which is used to treat various degenerative joint diseases and correct functional deformities, thus restoring function and alleviating symptoms.
No
The "Intended Use / Indications for Use" section lists conditions that the device treats (e.g., degenerative joint disease, rheumatoid arthritis, fractures, nonunion, failed arthroplasty), and the "Device Description" details parts of an orthopedic implant (polyethylene liners, ceramic heads). There is no mention of the device being used to identify, detect, or monitor a medical condition.
No
The device description clearly details physical components (polyethylene liners, ceramic heads, metallic femoral stem) and their materials, indicating it is a hardware medical device.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body (like blood, urine, tissue) to provide information about a person's health.
- Device Description and Intended Use: The provided information clearly describes a hip joint implant (acetabular liners and ceramic heads) used for surgical replacement of the hip joint. Its intended uses are related to treating various conditions affecting the hip joint through surgical intervention.
- Lack of Diagnostic Testing: There is no mention of this device being used to analyze biological samples or provide diagnostic information. Its function is purely mechanical and structural, replacing damaged parts of the hip joint.
Therefore, based on the provided information, this device is a surgical implant, not an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
-
- Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis.
-
- Rheumatoid arthritis.
-
- Correction of functional deformity.
-
- Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable using other techniques.
-
- Revision of previously failed total hip arthroplasty.
Intended for cemented and uncemented applications.
Product codes
LZO
Device Description
The ArComXLTM polyethylene liners are manufactured from highly cross-linked polyethylene conforming to ASTM F648 that was previously cleared in K042051. ArComXLTM is available in three designs: MaxRom, Hi-Wall, and 10o.
Biolox® delta Ceramic Heads (K042091) are composed of Transition-Toughened-Platelet-Alumina (TTPA). The highly polished spherical surface articulates with the ArComXLTM polyethylene liner acetabular component. The modular head attaches to a metallic femoral stem with a Biomet Type I taper.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Hip joint, proximal femur
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Volumetric wear testing was performed on ArComXLTM Acetabular Liners and the Biolox® delta Ceramic Liners showing less wear.
Clinical Testing: None provided as a basis for substantial equivalence.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
ArComXLTM Acetabular Liners (K042051), Biolox® delta Ceramic Heads (K042091)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 888.3353 Hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis.
(a)
Identification. A hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis is a device intended to be implanted to replace a hip joint. This device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. The two-part femoral component consists of a femoral stem made of alloys to be fixed in the intramedullary canal of the femur by impaction with or without use of bone cement. The proximal end of the femoral stem is tapered with a surface that ensures positive locking with the spherical ceramic (aluminium oxide, A12 03 ) head of the femoral component. The acetabular component is made of ultra-high molecular weight polyethylene or ultra-high molecular weight polyethylene reinforced with nonporous metal alloys, and used with or without bone cement.(b)
Classification. Class II.
0
KOTI411 o'//
JUN 2 9 2005
510(k) Summary
| Sponsor: | Biomet Manufacturing Corporation
56 East Bell Drive
P.O. Box 587
Warsaw, IN 46581-0587 |
|-----------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact Person: | Tracy Bickel Johnson, RAC |
| Proprietary Name: | ArComXLTM Acetabular Liners and Biolox® delta Ceramic Heads |
| Common Name: | Acetabular liners and ceramic heads |
| Classification Name: | LZO- hip joint/ceramic/polymer, semi-constrained, cemented or non-
cemented prosthesis (888.3353) |
| Substantially Equivalent Devices: | ArComXLTM Acetabular Liners (K042051)
Biolox® delta Ceramic Heads (K042091) |
| Device Description: | The ArComXLTM polyethylene liners are manufactured from highly cross-
linked polyethylene conforming to ASTM F648 that was previously cleared in
K042051. ArComXLTM is available in three designs: MaxRom, Hi-Wall, and
10o. |
| | Biolox® delta Ceramic Heads (K042091) are composed of Transition-
Toughened-Platelet-Alumina (TTPA). The highly polished spherical surface
articulates with the ArComXLTM polyethylene liner acetabular component.
The modular head attaches to a metallic femoral stem with a Biomet Type I
taper. |
| Indications for Use: | 1) Non-inflammatory degenerative joint disease including osteoarthritis and
avascular necrosis, 2) Rheumatoid arthritis, 3) Correction of functional
deformity 4) Treatment of nonunion, femoral neck and trochanteric
fractures of the proximal femur with head involvement, unmanageable
using other techniques, 5) Revision of previously failed total hip
arthroplasty. |
| | Intended for cemented and uncemented applications |
| Summary of Technologies: | The design, sizes, intended use, indications, contraindications, and
design specifications of the subject components remain identical to
their predicate component counterparts. This submission allows the
ArComXLTM Acetabular Liners and the Biolox® delta Ceramic Heads
to be used together. |
| Non-Clinical Testing: | Volumetric wear testing was performed on ArComXLTM Acetabular Liners
and the Biolox® delta Ceramic Liners showing less wear. |
| Clinical Testing: | None provided as a basis for substantial equivalence. |
All trademarks are property of Biomet, Inc.
1
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/1/Picture/2 description: The image is a black and white seal for the Department of Health & Human Services - USA. The seal is circular with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of three overlapping human figures.
JUN 2 9 2005
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Ms.Tracy Bickel Johnson Manager of Regulatory Affairs Biomet Incorporated P.O. Box 587 Warsaw, Indiana 46582
Re: K051411
Trade/Device Name: ArComXL™ Acetabular Liners and Biolox® delta Ceramic Heads Regulation Number: 21 CFR 888.3353 Regulation Name: Hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis Regulatory Class: II Product Code: LZO Dated: May 27, 2005 Received: May 31, 2005
Dear Ms. Johnson:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
2
Page 2 - Ms.Tracy Bickel Johnson
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours.
iriam C. Provost, Ph.D. Acting Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
Indications for Use
510(k) Number (if known):
Device Name: ArComXL™ Acetabular Liners and Biolox® delta Ceramic Heads
Indications For Use:
-
- Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis.
-
- Rheumatoid arthritis.
-
- Correction of functional deformity.
-
- Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable using other techniques.
-
- Revision of previously failed total hip arthroplasty.
Intended for cemented and uncemented applications
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Styp Rhodes
Sign-Off (Division Division of General, Restorative, and Neurologica! Devices
510(k) Number: K051411